Skip to main content
Clinical Trials/NCT01135030
NCT01135030CompletedNot Applicable

Anterior Referencing Vs. Posterior Referencing in Minimally Invasive Total Knee Arthroplasty

Heekin Orthopedic Research Institute2 sites in 1 country100 target enrollmentStarted: October 1, 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
100
Locations
2
Primary Endpoint
greater flexion after surgery

Study Overview

Brief Summary

The purpose of this study is to look at two different referencing systems for total knee replacement surgery. In anterior referencing system, referencing cuts are made from the front surface of the femur. This allows for a more exact cut. The anterior referencing system is more difficult for the surgeon to use. This may increase surgery time. Posterior referencing, on the other hand, references cuts from the back of the femur. The posterior referencing system is quick and easy for the surgeon to use. Posterior referencing may lead to notching of the femur. The risk of notching is very low and may not affect your results. This is a study that has never been done before. Dr. Heekin uses both referencing systems in his practice. He would like to determine which knee referencing system allows for greater knee flexion after surgery. Knee flexion correlates with function and the ability to return to everyday activities. For example, getting up from a chair, going up and down stairs, stooping, and kneeling.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
21 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient is a male or non-pregnant female between the ages of 21-
  • Patient requires cemented primary total knee replacement.
  • Patient has a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or avascular necrosis (AVN).
  • Patient has intact collateral ligaments.
  • Patient has signed and dated an IRB approved study specific consent form.
  • Patient is able and willing to participate in the study according to the protocol for the full length of expected term of follow-up, and to follow their physician's directions.
  • Patient has failed to respond to conservative treatment modalities.
  • Patient's contralateral knee is without symptomatic degenerative disease.

Exclusion Criteria

  • Patient has had a prior procedure of high tibial osteotomy, cruciate ligament reconstruction or patellectomy of the surgical knee.
  • Patient is morbidly obese (BMI >30).
  • Patient has a deformity at the involved knee greater than 45degrees of flexion, 45 degrees of varus or 45 degrees of valgus.
  • Patient has an active or suspected latent infection in or about the knee joint.
  • Patient has a malignancy in the area of the involved knee joint.
  • Patient has a diagnosed systematic disease that would affect the subject's welfare or overall outcome of the study (i.e. moderate to severe osteoporosis, Paget's disease, renal osteodystrophy) or is immunologically suppressed, or receiving steroids in excess of physiologic dose requirements.
  • Patient has a neurological deficit, which interferes with the patient's ability to limit weight bearing or places an extreme load on implant during the healing period.
  • Female patient is or plans to become pregnant during the course of the study.
  • Patient has a known sensitivity to device materials.
  • Patient has prior diagnosis of diabetic or peripheral neuropathy in operative extremity or other neurologic disease affecting limb strength (i.e. Polymyositis, multiple sclerosis).
  • Patient's bone stock is compromised by disease or infection, which cannot provide adequate support and/or fixation to the prosthesis.
  • Patient has a TKA on the contralateral side less than six months post-op.
  • Patient has participated in an orthopaedic clinical investigation involving the hip or knee joint in the last 12 months.

Outcomes

Primary Outcomes

greater flexion after surgery

Time Frame: 12 months

Secondary Outcomes

  • greater flexion after surgery(24 months)

Investigators

Sponsor
Heekin Orthopedic Research Institute
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

R. David Heekin

R. David Heekin, M.D.

Heekin Orthopedic Research Institute

Study Sites (2)

Loading locations...

Similar Trials